Guardian Pharmacy Services (GRDN) Cash from Financing Activities (2023 - 2026)

Guardian Pharmacy Services has disclosed Cash from Financing Activities across 4 years of filings, most recently posting -$2.0 million for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$2.0 million, up 23.56% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.4 million (up 68.84% YoY), and the FY2025 annual result was -$7.1 million, up 70.1% from the prior year.
• Cash from Financing Activities came in at -$2.0 million for Q1 2026 at Guardian Pharmacy Services, down from -$758000.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $44.9 million in Q3 2024 to a low of -$48.3 million in Q4 2024.
• The 4-year median for Cash from Financing Activities is -$2.4 million (2025), against an average of -$4.6 million.
• Across the five-year window, Cash from Financing Activities tumbled 263.62% in 2024 and jumped 98.43% in 2025, its largest moves.
• Guardian Pharmacy Services' Cash from Financing Activities stood at -$13.3 million in 2023, then sank by 263.62% to -$48.3 million in 2024, then surged by 98.43% to -$758000.0 in 2025, then slumped by 168.87% to -$2.0 million in 2026.
• The last three Cash from Financing Activities figures came in at -$2.0 million (Q1 2026), -$758000.0 (Q4 2025), and -$1.5 million (Q3 2025), per Business Quant data.